Researchers also found that Quality of Life improved and costs were lowered….
Read More »Monthly Archives: August 2014
Beta-Adrenergic Blockade Effects on Glucose Counterregulation in Advanced T2DM and Beta-Cell Failure
At normoglycemia, beta-adrenergic blockade may cause increased insulin sensitivity….
Read More »The Safety and Use of Oral Methazolamide in Type 2 Diabetes
Methazolamide, a carbonic anhydrase inhibitor, is a medication used to treat increased pressure inside the eye due to glaucoma….
Read More »Insulin Resistance’s Effects on Tissue Iron Stores and Cognitive Performance
BIO (brain iron overload) could be a potentially useful MRI biomarker for insulin resistance and obesity-associated cognitive dysfunction….
Read More »Empagliflozin (Jardiance) SGLT-2 Inhibitor Now Available in Pharmacies
The glucose-reducing drug empagliflozin (Jardiance) now has approval from the FDA after the drug maker corrected manufacturing problems that caused the agency to say “no” in March…. The sodium glucose cotransporter 2 (SGLT2) is indicated for improving glycemic control in adults with type 2 diabetes in conjunction with diet and …
Read More »Hypertension Control Can Prevent Renal Damage in Diabetics
Elevated blood pressure is associated with an increased risk of renal damage in patients with type 2 diabetes, especially if they have poor glycemic control….
Read More »New Way to Regenerate Beta Cells in Type 1 Diabetes
A peptide called caerulein can convert existing cells in the pancreas into insulin-generating beta cells….
Read More »Letter from the Editor, #744
This week I got to see exactly how easy it is for our patients to add extra calories and sugar to their daily routine. It seems that Labor Day is no longer a holiday worthy of a special section in the grocery store for holiday food. On August 14, grocery …
Read More »Editor’s Note, DCMS #203:
This week in Part 4 of our Homerun Slides series, Dr. Schwartz finishes up by looking at the treatments for LADA, MODY, type 1 and type 2 diabetes, and makes a case for using medications that replace or enhance incretin availability. He even delves into the idea of treating pre-diabetes …
Read More »IDF Diabetes Atlas – Southeast Asia
Diabetes is a huge and growing problem, and the costs to society are high and escalating. In Southeast Asia, half of people with diabetes are undiagnosed. The Top 5 countries for prevalence in this region are: Mauritius, India, Sri Lanka, Bangladesh, and Bhutan. To find out more, follow the link. …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.